Congenital Disorders of Glycosylation
The Congenital Disorders of Glycosylation session will be discussing overview of CDG and potential/existing treatments.
This educational activity is supported by an educational grant from Ultragenyx.
Hudson Freeze, MD
Sanford Burnham Prebys Medical Discovery Institute
Hudson Freeze, MD, speaker for this session, is a consultant for GlycoMIne, BridgeBio and Avalo Therapeutics.
Planners, faculty, and others in control of content (either individually or as a group) have no relevant financial relationships with ineligible companies.
All of the relevant financial relationships listed have been mitigated.
Children’s Hospital Colorado is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Children’s Hospital Colorado designates this Live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
A general certificate of attendance will be available after the completion of the online evaluation. Claim only credit commensurate of your conference attendance.
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Attendance